Temperature excursions may affect medication stability, and your provider or pharmacist can advise whether the vial remains safe to use
Tirzepatide, on the other hand, is a dual agonist, targeting both the GLP-1 and GIP receptors, offering enhanced glucose control and weight loss by combining the effects of both incretin hormones
The FDA prescribing information does not list specific interactions between tirzepatide and antibiotics, and no dose adjustments are required for either medication
Contact us to discuss your specific needs and get an accurate estimate for your peptide treatment
All strengths will be available from the manufacturer as the shortage has ended, but after April 22, 2025, compounding pharmacies will be only able to make custom doses